A Small Molecule Species Specifically Inhibits Fusarium Myosin I

Chengqi Zhang,Yun Chen,Yanni Yin,Huan-Hong Ji,Won-Bo Shim,Yiping Hou,Mingguo Zhou,Xiang-dong Li,Zhonghua Ma
DOI: https://doi.org/10.1111/1462-2920.12711
IF: 5.476
2015-01-01
Environmental Microbiology
Abstract:Fusarium head blight (FHB) caused by Fusarium graminearum is a devastating disease of cereal crops worldwide. Recently, a novel fungicide JS399-19 has been launched into the marketplace to manage FHB. It is compelling that JS399-19 shows highly inhibitory activity towards some Fusarium species, but not to other fungi, indicating that it is an environmentally compatible fungicide. To explore the mode of action of this species-specific compound, we conducted a whole-genome transcript profiling together with genetic and biochemical assays, and discovered that JS399-19 targets the myosin I of F.graminearum (FgMyo1). FgMyo1 is essential for F.graminearum growth. A point mutation S217L or E420K in FgMyo1 is responsible for F.graminearum resistance to JS399-19. In addition, transformation of F.graminearum with the myosin I gene of Magnaporthe grisea, the causal agent of rice blast, also led to JS399-19 resistance. JS399-19 strongly inhibits the ATPase activity of the wild-type FgMyo1, but not the mutated FgMyo1(S217L/E420K). These results provide us a new insight into the design of species-specific antifungal compounds. Furthermore, our strategy can be applied to identify novel drug targets in various pathogenic organisms.
What problem does this paper attempt to address?